Capillary Blood Glucose Monitoring Schedule for Pregnant Women with GDM on Insulin
For pregnant women with gestational diabetes mellitus on insulin therapy, perform capillary blood glucose monitoring four times daily: fasting plus either 1-hour or 2-hour postprandial measurements after each of the three main meals. 1
Monitoring Frequency
- Four times daily testing is the standard approach: one fasting measurement and three postprandial measurements (after breakfast, lunch, and dinner) 1, 2
- Testing every other day (four times on testing days) is a reasonable alternative for well-controlled GDM patients, as it maintains similar birth weights while improving compliance (92% vs 89%) 3
- However, the every-other-day approach should only be considered after an initial 7-day period of daily monitoring confirms good glycemic control without hyperglycemia requiring treatment adjustment 3
Timing of Postprandial Measurements
Choose either 1-hour OR 2-hour postprandial testing consistently—both are acceptable, though 1-hour monitoring may offer advantages:
1-Hour Postprandial Monitoring
- Target: <140 mg/dL (<7.8 mmol/L) 1
- Preferred approach based on superior outcomes: postprandial monitoring (versus preprandial) reduces neonatal hypoglycemia (3% vs 21%), macrosomia (12% vs 42%), and cesarean delivery for cephalopelvic disproportion (12% vs 36%) 4
- Results in lower insulin requirements compared to 2-hour monitoring 5
2-Hour Postprandial Monitoring
- Target: <120 mg/dL (<6.7 mmol/L) 1
- Equivalent neonatal outcomes to 1-hour monitoring in some studies 6
- May require more frequent insulin initiation 5
Fasting Glucose Targets
- 70-95 mg/dL (3.9-5.3 mmol/L) for GDM on insulin 1
- The lower limit of 70 mg/dL helps prevent hypoglycemia, which is a key concern with insulin therapy 1
Role of Continuous Glucose Monitoring (CGM)
- CGM may be beneficial for GDM on insulin but lacks the robust evidence base established for type 1 diabetes in pregnancy 1
- The decision to use CGM should be based on treatment complexity, patient preference, and available resources 1
- CGM provides valuable data on time in range and mean glucose but does not replace the need for targeted fasting and postprandial measurements for insulin adjustment 1
- Emerging evidence suggests potential benefits in reducing maternal and neonatal complications, though more research is needed specifically in the GDM population 7
Critical Pitfall to Avoid
Do not rely on preprandial monitoring alone—the landmark study by de Veciana et al. demonstrated that postprandial monitoring is superior to preprandial monitoring for preventing macrosomia and neonatal complications 4. The improvement in glycosylated hemoglobin was significantly greater with postprandial monitoring (-3.0% vs 0.6%), translating directly to better neonatal outcomes.
Insulin Adjustment Strategy
- Patient-led insulin titration is emerging as an effective approach: starting long-acting insulin at 10 units nightly with patient-directed adjustments of 2 units daily based on fasting glucose achieves glycemic control faster (1.8 vs 2.5 weeks) and reduces macrosomia (6.9% vs 37%) and large-for-gestational-age births (3.3% vs 34.6%) compared to clinician-led titration 8
- This approach requires clear patient education on the titration protocol but empowers patients and improves outcomes 8